LON:SNG Synairgen (SNG) Share Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free SNG Stock Alerts GBX 6.59 +0.19 (+2.97%) (As of 04/25/2024 09:21 PM ET) Add Compare Share Share Today's Range 6.20▼ 6.8550-Day Range 4.50▼ 7.5452-Week Range 4▼ 13.98Volume196,135 shsAverage Volume368,773 shsMarket Capitalization£13.27 millionP/E RatioN/ADividend Yield1.53%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Synairgen alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Synairgen Stock (LON:SNG)Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.Read More SNG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SNG Stock News HeadlinesApril 24, 2024 | americanbankingnews.comSynairgen (LON:SNG) Share Price Crosses Above 50 Day Moving Average of $5.45April 16, 2024 | americanbankingnews.comSynairgen (LON:SNG) Stock Price Crosses Above 50-Day Moving Average of $5.29April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 4, 2024 | morningstar.comSonagi SGPS SA SNGFebruary 8, 2024 | finance.yahoo.comSynairgen plc (SYGGF) Stock Historical Prices & Data - Yahoo FinanceFebruary 7, 2024 | uk.finance.yahoo.comSynairgen plc (SNG.L)January 22, 2024 | finance.yahoo.comCompanies Like Synairgen (LON:SNG) Are In A Position To Invest In GrowthDecember 23, 2023 | morningstar.comSynairgen PLC SYGGFApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.December 16, 2023 | morningstar.comSynairgen PLC OMYDecember 16, 2023 | morningstar.comSynairgen PLC SNGNovember 22, 2023 | morningstar.comSNGN Romgaz SA SNGOctober 11, 2023 | marketwatch.comSynairgen Finance Chief John Ward Steps Down; Colliver Named as ReplacementOctober 11, 2023 | proactiveinvestors.comSynairgen appoints new CFO as incumbent bows out after nearly 20 yearsSeptember 21, 2023 | proactiveinvestors.comSynairgen takes targeted approach with lead assetSeptember 21, 2023 | finance.yahoo.comSynairgen looking beyond COVID in fight against respiratory illnessJune 13, 2023 | finance.yahoo.comWe Think Synairgen (LON:SNG) Needs To Drive Business Growth CarefullyJune 9, 2023 | finance.yahoo.comSNG.L - Synairgen plcJanuary 4, 2023 | finance.yahoo.comCompanies Like Synairgen (LON:SNG) Could Be Quite RiskyOctober 4, 2022 | proactiveinvestors.comFTSE 100 jumps 140 points as L&G statement reassures - Proactive Investors USAOctober 4, 2022 | finance.yahoo.comSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19October 4, 2022 | businesswire.comSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19 - Business WireSeptember 30, 2022 | marketwatch.comSynairgen Shares Drop Amid Phase 3 Study Issues; Pretax Loss Narrows - MarketWatchSeptember 29, 2022 | lse.co.ukEARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens | Financial News - London South EastSeptember 29, 2022 | proactiveinvestors.comTesla appoints Airbnb co-founder Joe Gebbia to board - Proactive Investors USASeptember 20, 2022 | finance.yahoo.comSynairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022September 20, 2022 | marketscreener.comSynairgen's SNG001 Reduces Long COVID-19 Symptoms In Follow-up Visits After Late-stage Trial - Marketscreener.comSee More Headlines Receive SNG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Synairgen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/29/2020Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SNG CUSIPN/A CIKN/A Webwww.synairgen.com Phone+44-23-80512800FaxN/AEmployees34Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-42,870,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-48.86% Return on Assets-30.58% Debt Debt-to-Equity Ratio0.09 Current Ratio6.77 Quick Ratio6.35 Sales & Book Value Annual Sales£79,000.00 Price / Sales167.99 Cash FlowGBX 3.47 per share Price / Cash Flow1.90 Book ValueGBX 26 per share Price / Book0.25Miscellaneous Outstanding Shares201,380,000Free FloatN/AMarket Cap£13.27 million OptionableNot Optionable Beta-2.23 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Richard Marsden (Age 57)CEO, MD & Executive Director Comp: $328kProf. Stephen T. Holgate CBE (Age 77)M.D., Co-Founder, Non-Executive Director & Member of Scientific Advisory Board Comp: $44kDr. Phillip David Monk (Age 55)Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director Comp: $240kProf. Donna DaviesCo-Founder & Member of Scientific Advisory BoardProf. Ratko DjukanovicCo-Founder & Member of Scientific Advisory BoardMr. Joseph Tregonning Colliver F.C.A. (Age 44)CFO & Executive Director Dr. Gareth E. Walters Ph.D. (Age 65)Chief Regulatory Officer Ms. Jody BrookesSenior VP & Head of Clinical OperationsMr. Richard FrancisSenior VP and Head of CMC & QualityDr. Victoria TearHead of LaboratoryMore ExecutivesKey CompetitorsRealm TherapeuticsLON:RLMNetScientificLON:NSCIOndine BiomedicalLON:OBIOptiBiotix HealthLON:OPTISkinBioTherapeuticsLON:SBTXView All Competitors SNG Stock Analysis - Frequently Asked Questions How have SNG shares performed in 2024? Synairgen's stock was trading at GBX 5.98 at the beginning of 2024. Since then, SNG shares have increased by 10.3% and is now trading at GBX 6.59. View the best growth stocks for 2024 here. How were Synairgen's earnings last quarter? Synairgen plc (LON:SNG) released its earnings results on Tuesday, September, 29th. The company reported ($3.11) earnings per share (EPS) for the quarter. What other stocks do shareholders of Synairgen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Synairgen investors own include Alibaba Group (BABA), Yamana Gold (YRI), Eldorado Gold (ELD), Ocado Group (OCDO), Polo Resources (POL), Silvercorp Metals (SVM), W Resources (WRES), Associated British Foods (ABF), Ariana Resources (AAU) and First Majestic Silver (AG). How do I buy shares of Synairgen? Shares of SNG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SNG) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
